Longitudinal brain volume decline in PD with RBD and olfactory dysfunction
Objective: To elucidate longitudinal brain atrophies in PD with or without RBD and anosmia at baseline. Background: REM sleep behavior disorder (RBD) and olfactory dysfunction…Benefits of Physician-Pharmacist Collaboration on Patient Outcomes in Parkinson’s Disease and Movement Disorders Clinic
Objective: To evaluate the impact of pharmacist participation in Parkinson’s disease and movement disorders clinic on the number of drug-related problems (DRPs), clinical outcomes, and…monogenic parkinson´s disease in a chilean cohort
Objective: To describe the minimum prevalence and distribution of monogenic forms of PD in a chilean cohort Background: About 3–5% of Parkinson’s disease (PD) patients…Analysis of subthalamic-nuclei deep brain stimulation using radiomic feature-manifestations: a quantitative approach
Objective: To estimate STN by IPGs induced with DBS effects for Parkinson's by ‘radiomic-features(RF)’/symptoms-manifestations attained as of pre-opMRI, study possibility of ‘RF’ of amygdala-nucleus’ plus…Can a global measure of cognition be used to inform balance interventions in Parkinson’s disease?
Objective: To examine the relationship between domains of cognition, using the Montreal Cognitive Assessment (MoCA), and domains of balance, using the Mini Balance Evaluation Systems…Multimodal neuroimaging of Parkinson’s disease with diffusion tensor imaging (DTI) and dopamine transporter (DAT) positron emission tomography
Objective: The main aims of this study were to characterize brain microstructure alterations in a cross-sectional cohort of Parkinson’s disease (PD) with DTI and assess…Functional connectivity fingerprints in Parkinson’s disease patients with hallucinations
Objective: Investigate functional connectivity (FC) fingerprints of Minor Hallucinations (MH) in Parkinson’s Disease (PD). Background: MHs occur at the early stages of Parkinson’s disease in…Caregiver burden in Parkinson disease: an updated scoping review
Objective: We performed a scoping review to describe caregiver burden in Parkinson disease (PD) and build on the evidence provided by Mosely at al. [1]…Levodopa-entacapone-carbidopa intestinal gel infusion for Parkinson’s disease: An analysis of data collected from the Swedish national register of Parkinson’s disease.
Objective: To investigate efficacy, tolerability, and safety of levodopa-entacapone-carbidopa intestinal gel (LECIG) in Parkinson’s disease. Background: LECIG was introduced in 2019. The approval was based…Impact of non-motor fluctuations on QOL in patients with Parkinson’s disease
Objective: To investigate the impact of non-motor fluctuations for QOL in patients with Parkinson's disease (PwPD) using a nine-item wearing-off questionnaire (WOQ-9). Background: Long-term levodopa…
- « Previous Page
- 1
- …
- 143
- 144
- 145
- 146
- 147
- …
- 338
- Next Page »